TOSOH HLC-723G8 ANALYZER G8
Report
- Report Number
- 3005529799-2015-00013
- Event Type
- Injury
- Date Received
- January 5, 2016
- Date of Event
- December 18, 2015
- Report Date
- April 17, 2018
- Manufacturer
- TOSOH CORPORATION
- Product Code
- LCP
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Distributor report
- Reporter Location
- WI, US
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
(B)(4). REPORT SOURCE: HEALTH PROFESSIONAL. DATE RECEIVED BY MANUFACTURER: 21-DEC-2015. 510K: K071132. TYPE OR REPORT: FOLLOW-UP #: 1. TYPE OF REPORTABLE EVENT: MALFUNCTION. IF FOLLOW-UP, WHAT TYPE: CORRECTION, ADDITIONAL INFORMATION . DEVICE EVALUATED BY MFR: YES. (B)(4). USAGE OF DEVICE: REUSE. REVIEW OF THE G8 VARIANT ANALYSIS MODE TRAINING MANUAL INFORMS THE USER THAT IT IS VERY IMPORTANT THAT THE OPERATOR REVIEW THE CHROMATOGRAMS BEFORE REPORTING RESULTS. SECTION 5 OF THE MANUAL DISCUSSES INTERPRETING RESULTS SO THAT THE OPERATOR WILL BE ABLE TO IDENTIFY A NORMAL CHROMATOGRAM, UNDERSTAND REPORTABLE VS. NON-REPORTABLE RESULTS, AND IDENTIFY WHEN TO REPEAT A SAMPLE. (B)(4), PER EXEMPTION NUMBER E2017013. THIS REPORT IS BEING SUBMITTED DUE TO A RETROSPECTIVE REVIEW CONDUCTED UNDER CAPA-(B)(4).
ON 21-DEC-2015, TOSOH BIOSCIENCE WAS NOTIFIED THAT FOUR (4) PATIENT SPECIMENS TESTED FOR HBA1C ON THE TOSOH G8 ANALYZER HAD INCORRECT RESULTS REPORTED ON (B)(6) 2015. ONE OF THE SPECIMENS HAD BEEN REPORTED AS 6.5% AND THE PHYSICIAN QUESTIONED THE RESULT SINCE THE HBA1C PATIENT RESULTS ON (B)(6) 2015 WAS 7.55%. THE SPECIMEN WAS REPEATED ON (B)(6) 2015 AND THE RESULT WAS 7.3%. TOSOH TECHNICAL SUPPORT (TTS) REQUESTED THE CUSTOMER FAX A COPY OF THE CHROMATOGRAMS FOR REVIEW. AFTER EVALUATION OF THE CHROMATOGRAMS, TTS NOTED THAT THE BASELINE WAS ELEVATED ON THE ORIGINAL PRINTOUT OF THE 6.5% RESULT, AND WHEN REPEATED ON (B)(6) 2015 THE BASELINE WAS NORMAL WITH A RESULT OF 7.3%. DUE TO THESE FINDINGS, TTS ASKED THE CUSTOMER TO REVIEW ALL CHROMATOGRAMS FROM (B)(6) 2015. ALL THIRTY-THREE (33) PATIENT SPECIMENS TESTED ON (B)(6) 2015 WERE RERUN ON (B)(6) 2015. THE CHROMATOGRAMS FROM (B)(6) 2015 TESTING WERE REVIEWED AND FOUR (4) SPECIMENS ALL HAD INCREASED BASELINES AND UNACCEPTABLE CHROMATOGRAMS INDICATING THAT THE RESULTS SHOULD NOT HAVE BEEN REPORTED. THE CUSTOMER SENT OUT CORRECTED REPORTS FOR THE FOUR (4) PATIENT SPECIMENS THAT SHOULD NOT HAVE BEEN REPORTED. ON (B)(6) 2015, PREVENTIVE MAINTENANCE WAS PERFORMED ON THIS G8 ANALYZER, AND THE FOLLOWING WAS FOUND: COLUMN COUNT 1006, FILTER COUNT 102, RETENTION TIME 0.57 AND FLOW FACTOR 1.07. A TOSOH FIELD SERVICE ENGINEER (FSE) CALLED THE CUSTOMER TO DETERMINE WHAT COULD BE CAUSING THE ELEVATED BASELINES. THE FSE HAD THE CUSTOMER INSPECT THE INSTRUMENT FOR LEAKS AND NO LEAKS WERE FOUND. THE CUSTOMER WAS ALSO ASKED TO DO A DRAIN FLUSH TO GET RID OF ANY AIR IN THE LINES. FOLLOWING THE DRAIN FLUSH, THE PROBLEM SEEMED TO BE RESOLVED. ON (B)(6) 2015, THE CUSTOMER CALLED TO REPORT THAT NO FURTHER ELEVATED BASELINES OCCURRED SINCE (B)(6) 2015.
(B)(6) 2015 TOSOH BIOSCIENCE WAS NOTIFIED THAT 4 SPECIMENS TESTED FOR HBA1C ON THE TOSOH G8 ANALZYER HAD INCORRECT RESULTS REPORTED ON (B)(6) 2015. ONE OF THE SPECIMENS HAD BEEN REPORTED AS 6.5% AND THE PHYSICIAN QUESTIONED THE RESULT SINCE A (B)(6) 2015 HBA1C RESULT ON THE PATIENT HAD BEEN 7.55%. THE SPECIMEN WAS REPEATED ON (B)(6) 2015 AND THE RESULT WAS 7.3%. 33 SPECIMENS HAD BEEN TESTED SO WERE PULLED AND RETESTED. IN ADDITION TO THE INTIAL INCORRECT RESULT 3 OTHER SPECIMEN RESULTS DID NOT CORRELATE AND CORRECTED REPORTS WERE ISSUED. THE CHROMATOGRAMS FROM THE (B)(6) 2015 TESTING WERE REVIEWED AND THE FOUR SPECIMENS ALL HAD INCREASED BASELINES AND WERE NOT ACCEPTABLE CHROMATOGRAMS SO SHOULD NOT HAVE BEEN REPORTED. A TOSOH BIOSCIENCE FSE WAS DISPATCHED TO DETERMINE IF THERE WERE ANY ANALYZER ISSUES CAUSING THE ELEVATED BASELINES. ROOT CAUSE: AIR IN TUBING CAUSED ANALYZER INCORRECT RESULTS. INCORRECT RESULTS SHOULD HAVE BEEN IDENTIFIED DURING CHROMATOGRAM REVIEW BEFORE RESULTS RELEASED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 4499 | TOSOH HLC-723G8 ANALYZER G8 | G8 | LCP | TOSOH CORPORATION | G8 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other | STRECK QUALITY CONTROLS |